T1	PROC 82 107	evaluación de la eficacia
#1	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity
T2	CHEM 114 131	hidroxicloroquina
#2	AnnotatorNotes T2	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T3	CHEM 148 160	azitromicina
#3	AnnotatorNotes T3	C0052796; azithromycin; Antibiotic · Organic Chemical
T4	PROC 166 177	tratamiento
#4	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	DISO 186 204	infección COVID-19
T6	DISO 228 250	Infección por COVID-19
#5	AnnotatorNotes T6	C5203670; COVID19 (disease); Disease or Syndrome
T7	DISO 338 352	comorbilidades
#6	AnnotatorNotes T7	C1275743; Co-morbid conditions; Finding
T8	DISO 354 358	EPOC
#7	AnnotatorNotes T8	C0024117; Chronic Obstructive Airway Disease; Disease or Syndrome
T9	DISO 360 364	asma
#8	AnnotatorNotes T9	C0004096; Asthma; Disease or Syndrome
T10	DISO 366 377	cardiopatía
#9	AnnotatorNotes T10	C0018799; Heart Diseases; Disease or Syndrome
T11	DISO 379 382	HTA
#10	AnnotatorNotes T11	C0020538; Hypertensive disease; Disease or Syndrome
T12	DISO 384 392	diabetes
#11	AnnotatorNotes T12	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T13	DISO 394 403	neoplasia
#12	AnnotatorNotes T13	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T14	DISO 405 424	hepatopatía crónica
#13	AnnotatorNotes T14	C0341439; Chronic liver disease; Disease or Syndrome
T15	PROC 431 457	tratamiento inmunosupresor
#14	AnnotatorNotes T15	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T16	DISO 464 472	neumonía
#15	AnnotatorNotes T16	C0032285; Pneumonia; Disease or Syndrome
T17	DISO 501 525	Infección por SARS-CoV-2
#16	AnnotatorNotes T17	C5203670; COVID19 (disease); Disease or Syndrome
T18	DISO 330 335	COVID
T19	DISO 493 498	COVID
T20	PROC 567 579	radiográfica
#17	AnnotatorNotes T20	C1962945; Radiographic imaging procedure; Diagnostic Procedure
T21	DISO 596 604	neumonía
#18	AnnotatorNotes T21	C0032285; Pneumonia; Disease or Syndrome
T22	PROC 607 623	Saturación de O2
#19	AnnotatorNotes T22	C0523807; Oxygen saturation measurement; Laboratory Procedure
T23	PROC 698 734	consentimiento informado por escrito
#20	AnnotatorNotes T23	C0811741; Obtain informed written consent; Health Care Activity
T24	PROC 815 829	consentimiento
#21	AnnotatorNotes T24	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T25	PROC 1029 1043	ensayo clínico
#22	AnnotatorNotes T25	C0008976; Clinical Trials; Research Activity
T26	PROC 1051 1075	tratamiento experimental
#23	AnnotatorNotes T26	C2585119; Experimental therapeutic procedure; Therapeutic or Preventive Procedure
T27	DISO 1092 1109	Hipersensibilidad
#24	AnnotatorNotes T27	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T28	CHEM 1186 1197	excipientes
#25	AnnotatorNotes T28	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T29	CHEM 1252 1269	hidroxicloroquina
#26	AnnotatorNotes T29	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T30	DISO 1272 1289	Hipersensibilidad
#27	AnnotatorNotes T30	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T31	CHEM 1306 1318	eritromicina
#28	AnnotatorNotes T31	C0014806; erythromycin; Antibiotic · Organic Chemical
T32	CHEM 1361 1369	ketólido
T33	CHEM 1388 1399	excipientes
#29	AnnotatorNotes T33	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T34	CHEM 1454 1466	azitromicina
#30	AnnotatorNotes T34	C0052796; azithromycin; Antibiotic · Organic Chemical
T35	DISO 1469 1478	Psoriasis
#31	AnnotatorNotes T35	C0033860; Psoriasis; Disease or Syndrome
T36	DISO 1495 1538	déficit de glucosa-6-fosfato deshidrogenasa
#32	AnnotatorNotes T36	C2939465; Deficiency of glucose-6-phosphate dehydrogenase; Disease or Syndrome
T37	CHEM 1594 1611	hidroxicloroquina
#33	AnnotatorNotes T37	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T38	CHEM 1614 1626	azitromicina
#34	AnnotatorNotes T38	C0052796; azithromycin; Antibiotic · Organic Chemical
T39	DISO 1629 1637	Neumonía
#35	AnnotatorNotes T39	C0032285; Pneumonia; Disease or Syndrome
T40	DISO 1640 1656	Miastenia gravis
#36	AnnotatorNotes T40	C0026896; Myasthenia Gravis; Disease or Syndrome
T41	DISO 1659 1670	Maculopatía
#37	AnnotatorNotes T41	C0730362; Disorder of macula of retina; Disease or Syndrome
T42	ANAT 1688 1691	ojo
#38	AnnotatorNotes T42	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T43	DISO 1707 1752	alteraciones de la agudeza o del campo visual
T44	CHEM 1932 1941	artemeter
#39	AnnotatorNotes T44	C0052429; artemether; Organic Chemical · Pharmacologic Substance
T45	CHEM 1942 1954	lumefantrina
#40	AnnotatorNotes T45	C0531104; lumefantrine; Organic Chemical · Pharmacologic Substance
T46	PROC 1806 1832	Aclaramiento de creatinina
#41	AnnotatorNotes T46	C0373595; Creatinine clearance measurement; Laboratory Procedure
T47	PROC 1848 1866	Prueba de embarazo
#42	AnnotatorNotes T47	C0032976; Pregnancy Tests; Diagnostic Procedure
T48	PROC 1908 1919	Tratamiento
#43	AnnotatorNotes T48	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T49	CHEM 1956 1966	mefloquina
#44	AnnotatorNotes T49	C0025153; mefloquine; Organic Chemical · Pharmacologic Substance
T50	CHEM 2015 2027	pimecrolimus
#45	AnnotatorNotes T50	C1099414; pimecrolimus; Organic Chemical · Pharmacologic Substance
T51	CHEM 2029 2039	tacrolimus
#46	AnnotatorNotes T51	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T52	CHEM 2066 2088	agalsidasa alfa y beta
#47	AnnotatorNotes T52	C0962517; agalsidase alfa; Amino Acid, Peptide, or Protein · Enzyme · Pharmacologic Substance + C1137427; agalsidase beta; Amino Acid, Peptide, or Protein · Enzyme · Pharmacologic Substance
T53	CHEM 2050 2063	mosifloxacino
T54	PROC 2162 2176	procedimientos
#48	AnnotatorNotes T54	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T55	PROC 46 73	Ensayo clínico aleatorizado
#49	AnnotatorNotes T55	C0206034; Clinical Trials, Randomized; Research Activity
T56	CHEM 443 457	inmunosupresor
#50	AnnotatorNotes T56	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T57	PROC 541 554	prueba de PCR
T58	PROC 632 655	Frecuencia respiratoria
#51	AnnotatorNotes T58	C1443397; Taking respiratory rate; Health Care Activity
T59	CHEM 621 623	O2
#52	AnnotatorNotes T59	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T60	PROC 757 771	procedimientos
#53	AnnotatorNotes T60	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T61	CHEM 1137 1167	compuestos de 4-aminoquinolina
T62	CHEM 1292 1304	azitromicina
#54	AnnotatorNotes T62	C0052796; azithromycin; Antibiotic · Organic Chemical
T63	CHEM 1337 1358	antibiótico macrólido
T64	CHEM 1506 1538	glucosa-6-fosfato deshidrogenasa
#55	AnnotatorNotes T64	C0017757; Glucosephosphate Dehydrogenase; Amino Acid, Peptide, or Protein · Enzyme
T65	Observation 1755 1774	Prolongación del QT
#56	AnnotatorNotes T65	C0151878; Prolonged QT interval; Finding
T66	PROC 1785 1788	ALT
#57	AnnotatorNotes T66	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T67	PROC 1791 1794	AST
#58	AnnotatorNotes T67	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T68	CHEM 1822 1832	creatinina
#59	AnnotatorNotes T68	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T69	CHEM 1981 2013	vacunas de virus vivos atenuados
T70	CHEM 1113 1129	principio activo
#60	AnnotatorNotes T70	C1372955; Active ingredient; Chemical Viewed Functionally
T71	DISO 1081 1089	COVID-19
#61	AnnotatorNotes T71	C5203670; COVID19 (disease); Disease or Syndrome
T72	CHEM 1968 1979	natilizumab
T73	Date 13 17	2020
T74	Neg_cue 143 145	no
T75	LIVB 279 303	Pacientes de ambos sexos
#62	AnnotatorNotes T75	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T76	LIVB 306 315	Pacientes
#63	AnnotatorNotes T76	C0030705; Patients; Patient or Disabled Group
T77	Age 316 325	≥ 18 años
T78	Duration 417 424	crónica
#64	AnnotatorNotes T78	C0205191; chronic; Temporal Concept
T79	Neg_cue 460 463	sin
T80	Age 475 488	mayores de 60
T81	Neg_cue 583 585	no
T85	LIVB 857 865	testigos
#65	AnnotatorNotes T85	C0682356; Witnesses; Population Group
T87	LIVB 1481 1490	Pacientes
#66	AnnotatorNotes T87	C0030705; Patients; Patient or Disabled Group
T91	LIVB 1878 1905	Mujer con lactancia materna
#67	AnnotatorNotes T91	C4316174; Patients who are breastfeeding; Patient or Disabled Group
T92	PHYS 1888 1905	lactancia materna
#68	AnnotatorNotes T92	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T93	LIVB 1992 1997	virus
#69	AnnotatorNotes T93	C0042776; Virus; Virus
T94	Route 2041 2047	tópico
#70	AnnotatorNotes T94	C1522168; Topical Route of Drug Administration; Functional Concept
T96	LIVB 2114 2122	paciente
#71	AnnotatorNotes T96	C0030705; Patients; Patient or Disabled Group
T97	PHYS 1740 1752	campo visual
#72	AnnotatorNotes T97	C2370928; Visual field functions; Organ or Tissue Function
T98	PHYS 1858 1866	embarazo
#73	AnnotatorNotes T98	C0032961; Pregnancy; Organism Function
T101	LIVB 515 525	SARS-CoV-2
#74	AnnotatorNotes T101	C5203676; SARS-CoV-2; Virus
A1	Assertion T3 Negated
A2	Assertion T16 Negated
A3	Assertion T21 Negated
A4	Status T27 History_of
A5	Status T30 History_of
A6	Assertion T37 Contraindicated
A7	Assertion T38 Contraindicated
A8	Status T41 History_of
R1	Negation Arg1:T81 Arg2:T21
#75	AnnotatorNotes T5	C5203670; COVID19 (disease); Disease or Syndrome
#76	AnnotatorNotes T18	C5203670; COVID19 (disease); Disease or Syndrome
#77	AnnotatorNotes T19	C5203670; COVID19 (disease); Disease or Syndrome
#78	AnnotatorNotes T57	C0201657; C-reactive protein measurement; Laboratory Procedure
#79	AnnotatorNotes T63	C0003240; Macrolide Antibiotics; Organic Chemical · Antibiotic 
#80	AnnotatorNotes T32	C3824716; Ketolide antibiotics; Organic Chemical · Pharmacologic Substance 
T82	Neg_cue 2091 2099	Negativa
T83	Observation 2150 2176	cumplir los procedimientos
A9	Assertion T83 Negated
#81	AnnotatorNotes T83	C2364172; Adherence To Medication Regime; Finding (?)
R3	Negation Arg1:T82 Arg2:T83	
R4	Combined_with Arg1:T2 Arg2:T3	
R5	Negation Arg1:T74 Arg2:T3	
R6	Used_for Arg1:T2 Arg2:T4	
R7	Has_Age Arg1:T76 Arg2:T77	
R8	Experiences Arg1:T76 Arg2:T18	
R9	Overlap Arg1:T18 Arg2:T7	
R10	Experiences Arg1:T76 Arg2:T7	
R11	Experiences Arg1:T76 Arg2:T8	
R12	Experiences Arg1:T76 Arg2:T9	
R13	Experiences Arg1:T76 Arg2:T10	
R14	Experiences Arg1:T76 Arg2:T11	
R15	Experiences Arg1:T76 Arg2:T12	
R16	Experiences Arg1:T76 Arg2:T13	
R17	Has_Duration_or_Interval Arg1:T14 Arg2:T78	
R18	Experiences Arg1:T76 Arg2:T14	
R19	Experiences Arg1:T76 Arg2:T15	
R20	Used_for Arg1:T56 Arg2:T15	
R21	Overlap Arg1:T18 Arg2:T8	
R22	Overlap Arg1:T18 Arg2:T9	
R23	Overlap Arg1:T18 Arg2:T10	
R24	Overlap Arg1:T18 Arg2:T11	
R25	Overlap Arg1:T18 Arg2:T12	
R26	Overlap Arg1:T18 Arg2:T13	
R27	Overlap Arg1:T18 Arg2:T14	
R28	Overlap Arg1:T18 Arg2:T15	
R29	Overlap Arg1:T18 Arg2:T16	
R30	Negation Arg1:T79 Arg2:T16	
R31	Experiences Arg1:T76 Arg2:T16	
R32	Experiences Arg1:T76 Arg2:T19	
R33	Has_Age Arg1:T76 Arg2:T80	
R36	Causes Arg1:T101 Arg2:T17	
T84	Result_or_Value 624 629	> 92%
R39	Has_Result_or_Value Arg1:T22 Arg2:T84	
T86	Result_or_Value 656 664	< 20 rpm
R40	Has_Result_or_Value Arg1:T58 Arg2:T86	
T88	Observation 667 676	Dispuesto
#82	AnnotatorNotes T88	C0600109; Willing; Finding (?)
T89	Observation 679 684	capaz
#83	AnnotatorNotes T89	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R41	Overlap Arg1:T89 Arg2:T23	
R42	Overlap Arg1:T88 Arg2:T23	
R43	Before Arg1:T23 Arg2:T60	
T90	Quantifier_or_Qualifier 830 834	oral
#84	AnnotatorNotes T90	C0439824; Verbal; Qualitative Concept
R44	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T90	
T95	CONC 903 919	historia clínica
#85	AnnotatorNotes T95	C5204342; Clinical History; Intellectual Product
R45	Before Arg1:T24 Arg2:T95	
T99	Observation 997 1043	Participación en cualquier otro ensayo clínico
R46	Causes Arg1:T70 Arg2:T27	
R47	Causes Arg1:T61 Arg2:T27	
R48	Causes Arg1:T28 Arg2:T27	
R49	Causes Arg1:T29 Arg2:T27	
R50	Experiences Arg1:T87 Arg2:T36	
R51	Location_of Arg1:T42 Arg2:T41	
T100	Duration 1775 1782	+/- 450
R52	Has_Duration_or_Interval Arg1:T65 Arg2:T100	
T102	Result_or_Value 1795 1803	>5 x ULN
R53	Has_Result_or_Value Arg1:T67 Arg2:T102	
R54	Has_Result_or_Value Arg1:T66 Arg2:T102	
T103	Result_or_Value 1833 1845	<50 ml / min
R55	Has_Result_or_Value Arg1:T46 Arg2:T103	
R56	Experiences Arg1:T91 Arg2:T92	
T104	Result_or_Value 1867 1875	positiva
#86	AnnotatorNotes T104	C1446409; Positive; Finding
R57	Has_Result_or_Value Arg1:T47 Arg2:T104	
R59	Causes Arg1:T62 Arg2:T30	
R60	Causes Arg1:T31 Arg2:T30	
R61	Causes Arg1:T63 Arg2:T30	
R62	Causes Arg1:T32 Arg2:T30	
R63	Causes Arg1:T33 Arg2:T30	
R64	Causes Arg1:T34 Arg2:T30	
R65	Combined_with Arg1:T44 Arg2:T45	
R66	Used_for Arg1:T44 Arg2:T48	
T105	Quantifier_or_Qualifier 1920 1926	activo
#87	AnnotatorNotes T105	C0679217; Active State; Idea or Concept
R67	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T105	
R68	Used_for Arg1:T49 Arg2:T48	
#88	AnnotatorNotes T72	C1172734; natalizumab; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
R69	Used_for Arg1:T72 Arg2:T48	
#89	AnnotatorNotes T69	C1516086; Attenuated Live Virus Vaccine; Immunologic Factor · Pharmacologic Substance
R70	Used_for Arg1:T69 Arg2:T48	
R71	Used_for Arg1:T50 Arg2:T48	
R72	Has_Route_or_Mode Arg1:T51 Arg2:T94	
R73	Used_for Arg1:T51 Arg2:T48	
#90	AnnotatorNotes T53	C0536495; moxifloxacin; Antibiotic · Organic Chemical
R74	Used_for Arg1:T53 Arg2:T48	
R75	Used_for Arg1:T52 Arg2:T48	
R76	Experiences Arg1:T96 Arg2:T54	
#91	AnnotatorNotes T43	C3277708; Altered visual acuity; Finding | C2175576; nonspecific losses of visual field; Finding (?)
A10	Experiencer T75 Patient
A11	Experiencer T76 Patient
A12	Experiencer T85 Other
A13	Experiencer T87 Patient
A14	Experiencer T91 Patient
A15	Experiencer T96 Patient
